DMAAR vs TXN · $1.8M cap vs P/E 52, rev $10.29B
Drugs Made In America Acquisition Corp. Rights (DMAAR) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
DMAAR does not have a complete income-statement cache yet.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
DMAAR currently screens at market cap $1.8M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the DMAAR and TXN stock pages for the full models.
Not investment advice.